Chapter
1 – Dengue
v History
· History of being @ Dengue endemic area.
· Incubation period 3-14 days.
· (Many, prodrome, sensitive & specific
indicator, ~ for 2-3 days) chill,
erythemato’ skin’s mottling, facial flush.
· Child < 15 y.old usu’ (+) nonspecific febrile
syndr’ ~ + maculopapul’ rash.
· Classic dengue begins w/ sudden fever’s
onset, chills, severe (term: ‘breakbone’) ache @ head, back, & extremities,
+ other sympt’.
· Fever lasts 2-7 days & ~ reach 41OC
(if lasts > 10 days, ~ Ø due to Dengue).
· Other sympt’: Headache, Retroorbit’ pain, Generalized
pain (arthralg’, myalgia), Nausea, Emesis, & (rare) diarrhea, Rash, Weakn’,
Altered gustatory, Anorexia, Sore throat, Mild hemorrhag’ manifest’ (eg:
petechia, gum bleed’, epistaxis, ecchymoses, menorrhag’, hematuria), Lymphadenopathy.
· The rash (typic’ onset @ day 3, lasts for 2-3 days): Maculopapul’ or
macular confluent @ face, thorax, @ flexor surfaces, w/ skin-sparing islands.
· Fever (typic’) ↓ w/ ↓ed viremia.
Ocassional’, more @ child:
fever ↓ed for 1 day & then returns (‘saddleback’ fever)
· Second Rash (onset ~ @ 1-2 days of
defervescen’, lasts for 1-5 days): morbiliform, maculopapul’, Ø @ sole and
palm, ocassional’ desquam’.
· Slow & complete recovery, fatig’ &
exhaust’ ~ persist after fever subsided. Convalesc’
phase ~ lasts 2 weeks.
· Risk of Dengue Hemorrhag’ Fever (DHF) or Dengue
Shock Syndr’ onset @ Deverfescen’.
DHF Presaging: Abdomin’ pain +
restlessness, mental status change, hypotherm’, ↓ed platelet count.
· DHF’s 90% cases @ < 15 y.old.
Initial: similar to dengue
fever & other febrile viral ill’. (W/in
24 hours pre- to a bit after fever breaks) (+) Plasma leakage’s signs, +
(+) hemorrhag’ sympt’ s.as bleeding @ trauma & GI, & hematuria. Px ~ present w/ abdomin’ pain, emesis,
febrile seizures (@ child), & ↓ed consciousn’.
If untreated (most
likely) à Dengue Shock Syndr’. (Common sympt’ of
impending shock) Abdomin’ pain, emesis, & restless’, ~ + circulato’ fail’.
() Sympt’ onset after > 2 weeks since
left Dengue endemic area ~ Ø Dengue.
v Physic’ Exam’
· Acute Febrile Ill’ + 1 of:
o +++ &
generalized headache.
o Initial febrile
phase lasts 3-4 days, then remission of few hours to few days.
o Retroorbitalgia.
o +++ myalgia,
espec’ @ lumbar & extremit’.
o Arthralgia usu @
knee & shoulder.
o Rash @ 80% cases
set on during fever remission.
Characteris’
start on hand & feet’s dorsum spread to arms, legs, torso, & (rare)
face.
Lasts
2 hours – several days.
Before
(+) rash, hard to distinguish w/ yellow fever, malaria, & influenza.
o Hemorrhag’
manifest’.
o Leukopenia.
o Depression
· ~ +:
o Injected
conjunctiva.
o Facial flush’ (sensitive
& spec’ predictor of dengue)
o Inflamed pharynx
o Lymphadenopathy
o Nausea & emesis
o Dry cough
o Tachycardia,
bradycardia, and conduction defects.
· (50% cases) Px w/ characteris’ rash (~ maculopapul, scarlatiniform,
petechial, or macul’).
· Hemorrhag’ manifest’ also: (most
common)petechia & bleed’ @ venipunct’ site; petechia, nasal or gum bleed’,
melena, hematemes’, & menorrhag’.
· Usu’ (+) Torniquet Test:
o Inflate
bloodpress’ cuff @ upper arm to between systole & diastole pressu’ for 5
minutes.
o Then, if @ area
under pressu’ ≥ 3 petechia/cm2 or 20 petechia/inch2 à (+).
· (Rare) Seizure, & encephalopathy w/o typical dengue sympt’.
· Neurol’ complic’: neuropathy, Guillan-Barre syndr’,
transverse myelit’.
· @ Dengue Hemorrhagic Fever
o Similar to Dengue
Fever, include: biphasic fever curve, hemorrhag’ manifest’ > Dengue Fever’s,
signs of peritoneal- & or pleur’-effusion.
o Minimal diagnostic criteria:
· Fever
· Hemorrhag’ manifest’ (eg.: hemoconcentration,
thrombocytopenia, Torniquet Test (+)).
· Circulat’ fail’, s.as: signs of vascul’ permeabil’ (eg:
hypoproteinemia, effusion).
· Hepatomegaly.
o (30% cases) Injection Conjunctiva.
o Optic Neuropathy –(ocassional’)à permanent & +++ visual impair’.
o Generalized lymphadenopathy.
o (97% cases) Pharyngeal Injection.
o Hepatomega’ more often @ Dengue Shock Syndr’.
o Hepatic Transaminase ↑ ~ mild –
moderate.
o (Rare, Complic’) Encephalopathy ~ result from
combinat’ of hyponatremia, hepatic injury, anoxia, cerebr’ edema, &
intracrani’ hemorrhage.
· @ Dengue Shock Syndr’
o Hypotension
o Brady♥ (paradoxical) or tachy♥ related to hypovolem’ shock.
o Hepatomega’
o Hypotherm’
o Narrow Pulse Pressu’
o Signs of ↓ed Peripher’ Perfus’.
v Differ’ Diagnos’
() (Rare) Vertical
transmission (mother (w/ dengue @ peripartum) to neonate) à Neonate should be evaluated for dengue w/ platelet
count & serologic studies.
· Pregnancy Preeclampsia
o Overlap’ sympt’: thrombocytopenia, liver dysfunct’,
capillary leak, ascites, ↓ed uria. Definitive
diagnosis via serology testing.
· Viral Hemorrhagic Fevers
· Malaria
· Yellow fever
· Rift Valley fever
· St. Louis encephalitis
· Influenza
· Mayaro fever
· Ross River fever
· Sindbis virus
· Ebola virus
· River Virus
· Chikungunya Orbivirus
· West Nile encephalitis
· Roseola infantum
· Scarlet fever
· Idiopathic thrombocytopenic purpura
· Arenaviruses
· Leptospirosis
· Meningitis
· Rickettsial Infection
o Typhus (eg: Scrub Typhus)
o Spotted Fever (eg: Rocky Mountain Spotted Fever)
· Viral Hepatitis
v Workup
· Lab criter’ for diagn’ needs 1 or more of:
o Dengue virus isolat’ from serum, plasma, WBC, or
autopsy sample.
o Demonstrated ≥ 4x change in reciprocal IgG or IgM titer
to ≥ 1 dengue virus in paired serum samples.
o Demonstrated dengue verus Antigen in autopsy sample via immunohistochem’ or
immunofluoresc’ or in serum sample
via enzyme immuno assay (EIA).
o Detected viral genomic sequences in autopsy,
serum, or CSFluid samples via PCR.
· (14 Mar 2014,
current’ only @ research lab) RT-PCR for rapid
& serotype-specif’ diagn’.
· Should also (+) tests:
o Complete Blood Count
o Metabolic Panel
o Serum protein & albumin level
o Liver panel
o Disseminated Intravascular Coagulation (DIC) panel
· Guaiac test should be performed on suspected
Dengue Px, due to subtle early coagulopathy signs.
· Typing & Crossmatching Blood should be done @
severe DHF or Dengue Shock Syndr’ because blood products ~ needed.
· Urinalysis looks for hematuria.
· Culture of blood, urine, CSFluid, & other body
fluid should be done as needed to find Px’s condition’s etio’.
· Arterial blood gas should be assessed in severe cases
to know pH, O2ation, & ventilat’.
· ECG ~ demonstrate Øspecif’ changes due to
fever, electrolyte disturban’, tachy♥, or medicat’.
Unclear usefuln’ in looking for ♥
involvem’s markers.
· Skin lesion biopsy @ nonfatal, uncomplic’ Dengue shows
abnormal @ blood vessels.
· Skin lesion biopsy (primary finding): Endothelial
swell’, perivascul’ edema, MN cell infiltration.
· Chest radiography to look for pleural effus’ (typic’:
right-sided) & bronchopneumon’.
· (Common) Bilateral pleural effus’ @ Dengue Shock
Syndr’.
· Head CT w/o contrast ~ done @ altered
mental status to look for intracran’ bleed’ or cerebr’ edema from DHF.
· Complete Blood Count
o (Observed near end of febrile phase, more +++ >
other febrile ill’ in dengue-epidemic area) Leukopenia, neutropenia,
thrombocytopenia (characterist’ < 100,000 platelet/μL, 50% cases), oft’ +
lymphopenia.
o Lymphocytosis, w/ atypic’ lymphocyt’, commonly (+) pre-
defervescen’ or shock.
o Hematocrit: ↑ > 20% (due to plasma
extravasat’ & or 3rd space fluid loss)
à sign of
hemoconcentration, precedes shock.
Should be monitored every ≤
24 hours to helf early-find DHF; every 3-4 hours in severe DHF or Dengue Shock Syndr’.
o Thrombocytopenia (< 100,000 platelet/μL) @ DHF or Dengue Shock Sydnr’ precede
defervescen’ & shock’s onset. Platelet
count should be monitored every ≤ 24 hours to early-find DHF.
· Metabolic Panel & Liver Enzymes
o (Most common
electroly’ abnorm’ @ DHF or Dengue Shock Syndr’) Hyponatremia.
o (@ Px w/ Shock)
↑ed BUNitrogen, & (must be corrected
quick’) Metabolic acidosis.
o (Uncommon) Acute renal injury.
o Mild’ ↑ed
transaminase levels to several kilo @
DHF w/ Acute hepatit’.
o Hypoalbuminem’s sign of hemoconcentrat’.
· Coagulation studies
o ~ help guide
therapy in Px w/ severe hemorrhag’ manifest’.
o Findings:
· Prolonged prothrombin time.
· Prolonged activated partial thromboplastin time.
· Low fibrinogen & ↑ed fibrin degradat’ product
levels’re
signs of DIC.
· Serum studies
o For serodiagnosis (basis: ↑ed antibody
titer @ paired specim’ taken during acute stage & convalesc’ phase), PCR, & virus isolati’.
o Results vary
depend' on whether it’s 1stary or 2ndary infec’.
o IgM capture
enzyme-linked immunosorbent assay (MAC-ELISA)’s most widely used for dengue’s serologic assay.
o Other tests:
· Complement Fixation (CF)
· Neutralization Test (NT)
· Hemagglutination Inhibition (HI)
· IgG ELISA
· NS1 Strip Test
o Take serum sample (then immediat’ put on white ice
& send to lab) a.s.a.possib’ after
ill’s onset & after death or discharge from hospital.
Then,
take 2nd serum sample (for
convalescent-phase serolog’ test’) 7 –
21 (ideal: 10) days after acute serum sample.
o 1 positive PanBio-
IgG or IgM’s high rate of false positive
& should be confirmed using via more sensitive diagn’ test, otherwise,
platelet & WBC count can be helpful (thrombocytopenia
& leukopenia (+) @ 40.4% confirmed cases, 6.1% false positive cases).
· USG
o Potential’ timely,
cost-effective, easily-used in evaluati’ potential DHF.
o Positive & reliable findings: fluid in chest
& abdomin’ caviti’, pericard’ effus’, & (~ presages clinical’ signific’ vascul’ permeabi’)
thicken’ gallbladder wall.
o Daily chest & abdomin’ USG’s useful @ evaluati’ Px w/
suspected DHF.
o (Some) Plasma leakage’s detected w/in 3 days of
fever onset (most common: pleural effus’).
o (Some) Predicted DHF @ Pxs before (+)
hemoconcentration’s criteria.
· Case Definitions
o Suspected Dengue = compatible w/ clinical description.
o Probable Dengue = Suspected Dengue + ≥ 1 of these:
· Supportive serology (reciprocal HI antibody titer >
1280, comparable IgG EIA titer, or positive IgM antibody test @ late acute or
convalsesc’ phase serum sample).
· Occur @ same time & place as other confirmed
dengue cases.
o Confirmed Dengue = Suspected Dengue + Lab’s
confirmation.
o DHF’s Diagnos’ Criteria: probable- or
confirmed-case of Dengue & hemorrhag’ tendenc’ signed by:
· (Positive) Torniquet Test
· Petechia, Ecchymoses, or Purpura.
· Bleed’ of mucosal, GI, injection sites, or other.
· Hematemesis or
melena & Thrombocytopenia (< 100,000 cells/μL).
· Evident’ Plasma Leakage due to ↑ed
vascul’ permeabil’.
o Plasma leakage manifest’:
· > 20% ↑ in average hematocrit level for age &
sex.
· >20% ↓ in hematocrit following volume replacement
compared w/ baseline.
· Plasma leakage’s signs (eg: pleural
effus’, ascites, hypoproteinem’).
o (+) Dengue Shock Syndr’ Diagnosis = DHF + evident
circulat’ fail’ s.as:
· Rapid, weak pulse
· Narrow pulse pressu’ (< 20mmHg), w/
↑ed peripher’ vascul’ resistan’ (PVR) & ↑ed diastol’ pressu’.
· Hypotension
· Cool, clammy skin
· Altered mental status, although Px’s
initial’ alert.
o Shock onset ~ subtle, signed by: ↑ed
diastol’ pressu’ & ↑ed PVR in alert Px.
1. http://emedicine.medscape.com/article/215840-clinical
2. http://emedicine.medscape.com/article/215840-differential
3. http://emedicine.medscape.com/article/215840-workup
2. http://emedicine.medscape.com/article/215840-differential
3. http://emedicine.medscape.com/article/215840-workup
No comments:
Post a Comment